Again, CART analysis selected the 1.75 mRNA level as the best cut-off to classify patients in two risk groups: a high-risk group whose tumors expressed a RAB25 mRNA level below 1.75 and a low-risk group with a RAB25-tumor mRNA level above 1.75. The gene discussed is RAB25; the disease is neoplasm.